Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.24 USD | -0.03% | +5.88% | -60.42% |
01/05 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading | MT |
01/05 | HSBC Upgrades Endava to Buy From Hold, Price Target at $45 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 49.84 and 30.17 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-60.42% | 1.82B | C+ | ||
-14.59% | 188B | A- | ||
+1.84% | 166B | B+ | ||
-0.17% | 151B | B- | ||
+3.74% | 101B | A- | ||
+5.18% | 77.06B | A- | ||
+19.61% | 71.46B | C- | ||
-8.33% | 70.46B | A | ||
-21.32% | 52.14B | C | ||
-7.19% | 44.34B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DAVA Stock
- Ratings Endava plc